Filing Details

Accession Number:
0001225208-18-003484
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-20 19:46:38
Reporting Period:
2018-02-15
Accepted Time:
2018-02-20 19:46:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
200406 Johnson & Johnson JNJ Pharmaceutical Preparations (2834) 221024240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559387 Paulus Stoffels One Johnson & Johnson Plaza
New Brunswick NJ 08933
Exec Vp, Chief Scientific Off No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-15 155,342 $90.44 357,906 No 4 M Direct
Common Stock Disposition 2018-02-15 155,342 $129.86 202,564 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Options (Right to Buy) Disposition 2018-02-15 155,342 $0.00 155,342 $90.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-02-11 2024-02-09 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $129.435 to $130.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.